Small changes to IRT, EDC, and CTMS systems can quietly break validation. See why change control, testing, and documented approvals matter before deployment in a trial.
- When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
- Segregation Of Duties: Drug Accountability Needs Three Separate Roles
- When Clinical Demand Becomes A Supply Plan
- Before The Excursion: The Governance Decisions That Should Already Be Made
ON-DEMAND WEBINARS
Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
The COVID-19 global pandemic took the world by storm, disrupting several industries and our global supply chains. Learn why having a contingency plan and proactively planning gives a company a competitive edge.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
![GettyImages-1212860058 clinical trial patient]( "24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments")
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical ShipmentsGet an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
![iStock-1224887299-box-logistics-package]( "Clinical, Commercial Packaging: Delivering Next-Gen Therapies")
Clinical, Commercial Packaging: Delivering Next-Gen TherapiesSee how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
![Woman Typing On Laptop GettyImages-1148023189]( "Finding An RTSM Software To Keep Up With A Small Biotech")
Finding An RTSM Software To Keep Up With A Small BiotechStop letting rigid RTSM builds stall your oncology trials. Learn how agile configuration and right-sized documentation keep Phase I studies on track during frequent protocol amendments.
-
![GettyImages-2169608710-blister-packaging-pill-nutraceutical]( "Rare Diseases And The Integrated CDMO Support System")
Rare Diseases And The Integrated CDMO Support SystemChampion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.
-
![iStock-649856194-doctor-packaging-trial]( "Logistics, Transport Challenges Require Complex Solutions")
Logistics, Transport Challenges Require Complex SolutionsThe pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
![trends-for-2025-GettyImages-2161094939]( "Outlook 2025: Key Trends & Insights")
Outlook 2025: Key Trends & InsightsDive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
![GettyImages-1266357505-vaccine-development-lab]( "How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs")
How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial NeedsWhen selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.
-
![Vaccine injectable vials and syringe GettyImages-1252804942]( "Developing Injectable Drug Placebo Formulations For Clinical Trials")
Developing Injectable Drug Placebo Formulations For Clinical TrialsDeveloping a placebo for an injectable drug requires consideration of the formulation’s impact in trials, chemistry and physical details, ethical concerns, and regulatory compliance.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling")
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product PoolingSee how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
- Root Causes, Part 1: When Trial Design Locks In Supply Risk
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
